Lanean...
Bispecific Antibodies in Prostate Cancer Therapy: Current Status and Perspectives
SIMPLE SUMMARY: Despite recent advances in treatment, metastasized prostate carcinoma (PC) still has a poor prognosis. Immunotherapy has revolutionized the landscape of cancer therapy, but a breakthrough for PC is missing. The success of immunotherapy in cancers is mostly due to recent strategies to...
Gorde:
| Argitaratua izan da: | Cancers (Basel) |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867165/ https://ncbi.nlm.nih.gov/pubmed/33535627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030549 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|